Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations

Abstract Clinical translation of pluripotent stem cell (PSC) derivatives is hindered by the tumorigenic risk from residual undifferentiated cells. Here, we identified salicylic diamines as potent agents exhibiting toxicity to murine and human PSCs but not to cardiomyocytes (CMs) derived from them. H...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karsten Burkert, Hadiseh Taheri, Sarkawt Hamad, Matteo Oliverio, Gabriel Peinkofer, Jan-Wilhelm Kornfeld, Wacharee Harnying, Kurt Pfannkuche, Jürgen Hescheler, Albrecht Berkessel, Tomo Šarić
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c42a4101eb364861aadfd22f6d533faa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c42a4101eb364861aadfd22f6d533faa
record_format dspace
spelling oai:doaj.org-article:c42a4101eb364861aadfd22f6d533faa2021-12-02T13:57:58ZSalicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations10.1038/s41598-021-81351-z2045-2322https://doaj.org/article/c42a4101eb364861aadfd22f6d533faa2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81351-zhttps://doaj.org/toc/2045-2322Abstract Clinical translation of pluripotent stem cell (PSC) derivatives is hindered by the tumorigenic risk from residual undifferentiated cells. Here, we identified salicylic diamines as potent agents exhibiting toxicity to murine and human PSCs but not to cardiomyocytes (CMs) derived from them. Half maximal inhibitory concentrations (IC50) of small molecules SM2 and SM6 were, respectively, 9- and 18-fold higher for human than murine PSCs, while the IC50 of SM8 was comparable for both PSC groups. Treatment of murine embryoid bodies in suspension differentiation cultures with the most effective small molecule SM6 significantly reduced PSC and non-PSC contamination and enriched CM populations that would otherwise be eliminated in genetic selection approaches. All tested salicylic diamines exerted their toxicity by inhibiting the oxygen consumption rate (OCR) in PSCs. No or only minimal and reversible effects on OCR, sarcomeric integrity, DNA stability, apoptosis rate, ROS levels or beating frequency were observed in PSC-CMs, although effects on human PSC-CMs seemed to be more deleterious at higher SM-concentrations. Teratoma formation from SM6-treated murine PSC-CMs was abolished or delayed compared to untreated cells. We conclude that salicylic diamines represent promising compounds for PSC removal and enrichment of CMs without the need for other selection strategies.Karsten BurkertHadiseh TaheriSarkawt HamadMatteo OliverioGabriel PeinkoferJan-Wilhelm KornfeldWacharee HarnyingKurt PfannkucheJürgen HeschelerAlbrecht BerkesselTomo ŠarićNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Karsten Burkert
Hadiseh Taheri
Sarkawt Hamad
Matteo Oliverio
Gabriel Peinkofer
Jan-Wilhelm Kornfeld
Wacharee Harnying
Kurt Pfannkuche
Jürgen Hescheler
Albrecht Berkessel
Tomo Šarić
Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations
description Abstract Clinical translation of pluripotent stem cell (PSC) derivatives is hindered by the tumorigenic risk from residual undifferentiated cells. Here, we identified salicylic diamines as potent agents exhibiting toxicity to murine and human PSCs but not to cardiomyocytes (CMs) derived from them. Half maximal inhibitory concentrations (IC50) of small molecules SM2 and SM6 were, respectively, 9- and 18-fold higher for human than murine PSCs, while the IC50 of SM8 was comparable for both PSC groups. Treatment of murine embryoid bodies in suspension differentiation cultures with the most effective small molecule SM6 significantly reduced PSC and non-PSC contamination and enriched CM populations that would otherwise be eliminated in genetic selection approaches. All tested salicylic diamines exerted their toxicity by inhibiting the oxygen consumption rate (OCR) in PSCs. No or only minimal and reversible effects on OCR, sarcomeric integrity, DNA stability, apoptosis rate, ROS levels or beating frequency were observed in PSC-CMs, although effects on human PSC-CMs seemed to be more deleterious at higher SM-concentrations. Teratoma formation from SM6-treated murine PSC-CMs was abolished or delayed compared to untreated cells. We conclude that salicylic diamines represent promising compounds for PSC removal and enrichment of CMs without the need for other selection strategies.
format article
author Karsten Burkert
Hadiseh Taheri
Sarkawt Hamad
Matteo Oliverio
Gabriel Peinkofer
Jan-Wilhelm Kornfeld
Wacharee Harnying
Kurt Pfannkuche
Jürgen Hescheler
Albrecht Berkessel
Tomo Šarić
author_facet Karsten Burkert
Hadiseh Taheri
Sarkawt Hamad
Matteo Oliverio
Gabriel Peinkofer
Jan-Wilhelm Kornfeld
Wacharee Harnying
Kurt Pfannkuche
Jürgen Hescheler
Albrecht Berkessel
Tomo Šarić
author_sort Karsten Burkert
title Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations
title_short Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations
title_full Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations
title_fullStr Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations
title_full_unstemmed Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations
title_sort salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c42a4101eb364861aadfd22f6d533faa
work_keys_str_mv AT karstenburkert salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT hadisehtaheri salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT sarkawthamad salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT matteooliverio salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT gabrielpeinkofer salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT janwilhelmkornfeld salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT wachareeharnying salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT kurtpfannkuche salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT jurgenhescheler salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT albrechtberkessel salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
AT tomosaric salicylicdiaminesselectivelyeliminateresidualundifferentiatedcellsfrompluripotentstemcellderivedcardiomyocytepreparations
_version_ 1718392284278423552